Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Clin EEG Neurosci. 2021 Nov;52(6):400-405. doi: 10.1177/1550059420982706. Epub 2020 Dec 23.
Deficits in synchronous, gamma-frequency neural oscillations may contribute to schizophrenia patients' real-world functional impairment and can be measured electroencephalographically using the auditory steady-state response (ASSR). Gamma ASSR deficits have been reported in schizophrenia patients and individuals at clinical high risk (CHR) for developing psychosis. We hypothesized that, in CHR patients, gamma ASSR would correlate with real-world functioning, consistent with a role for gamma synchrony deficits in functional impairment.
A total of 35 CHR patients rated on Global Functioning: Social and Role scales had EEG recorded while listening to 1-ms, 93-dB clicks presented at 40 Hz in 500-ms trains, in response to which 40-Hz evoked power and intertrial phase-locking factor (PLF) were measured.
In CHR patients, lower 40-Hz PLF correlated with lower social functioning.
Gamma synchrony deficits may be a biomarker of real-world impairment at early stages of the schizophrenia disease trajectory.
同步、伽马频率神经振荡的缺陷可能导致精神分裂症患者在现实世界中的功能障碍,并且可以使用听觉稳态反应 (ASSR) 通过脑电图进行测量。已有研究报道精神分裂症患者和处于精神病发展临床高风险 (CHR) 的个体存在伽马 ASSR 缺陷。我们假设,在 CHR 患者中,伽马 ASSR 将与现实世界的功能相关,这与伽马同步缺陷导致功能障碍的作用一致。
共有 35 名 CHR 患者在聆听以 40 Hz 重复 500 ms 的 1 ms、93 dB 点击时记录脑电图,对其进行测量以获得 40 Hz 诱发功率和试验间相位锁定因子 (PLF)。
在 CHR 患者中,较低的 40 Hz PLF 与较低的社会功能相关。
伽马同步缺陷可能是精神分裂症疾病轨迹早期现实世界损伤的生物标志物。